Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of Infections Due to MDR Gram-Negative Bacteria

16 Apr 2019

Abstract excerpt

The treatment of multidrug-resistant Gram-negative bacteria (MDR-GNB) infections in critically ill patients presents many challenges. Since an effective treatment should be administered as soon as possible, resistance to many antimicrobial classes almost invariably reduces the probability of adequate empirical coverage, with possible unfavorable consequences. In this light, readily available patient’s medical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Enterobacteriaceae and Cronobacter Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31041313
DOI: 10.3389/fmed.2019.00074

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment of Infections Due to MDR Gram-Negative BacteriaPMID 31041313Read ↗

The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?Semantic proximity Read ↗

Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternativesSemantic proximity Read ↗

Developments on antibiotics for multidrug resistant bacterial Gram-negative infectionsSemantic proximity Read ↗

Bugs, hosts and ICU environment: countering pan-resistance in nosocomial microbiota and treating bacterial infections in the critical care setting.Semantic proximity Read ↗

Mechanisms of Antibiotic Resistance in Important Gram-Positive and Gram-Negative Pathogens and Novel Antibiotic SolutionsSemantic proximity Read ↗

Carbapenemase-Producing Gram-Negative Bacteria: Current Epidemics, Antimicrobial Susceptibility and Treatment OptionsSemantic proximity Read ↗

Current and future perspectives in the treatment of multidrug-resistant Gram-negative infectionsSemantic proximity Read ↗

Bacterial pneumonia associated with multidrug-resistant Gram-negative pathogens: Understanding epidemiology, resistance patterns, and implications with COVID-19Semantic proximity Read ↗

Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming ApproachesSemantic proximity Read ↗

Mechanisms of antimicrobial resistance in Gram-negative bacilliSemantic proximity Read ↗

In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes-Study for Monitoring Antimicrobial Resistance Trends, United States 2015-2017.Semantic proximity Read ↗

Prevalence and Determinants of Antimicrobials Resistance of Pathogens Among Cancer Patients in Intensive Care UnitsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.